Sage Therapeutics
SAGE
#7026
Rank
C$0.75 B
Marketcap
C$11.95
Share price
0.00%
Change (1 day)
5.03%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -C$0.43 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are C$70.41 Million. In 2024 the company made an earning of -C$0.56 Billion, an increase over its 2023 earnings that were of -C$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.43 Billion-23.69%
2024 -C$0.56 Billion-26.01%
2023 -C$0.75 Billion1.63%
2022 -C$0.74 Billion16.36%
2021 -C$0.64 Billion-175.55%
2020 C$0.83 B-189.1%
2019 -C$0.94 Billion82.43%
2018 -C$0.52 Billion38.04%
2017 -C$0.38 Billion69.9%
2016 -C$0.22 Billion68.25%
2015 -C$0.14 Billion179.48%
2014 -C$46.57 Million84.98%
2013 -C$25.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-C$65.32 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
C$49.1 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
C$0.70 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-C$79.89 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA